BR Brands Acquires Mary's Brands (Mary's Medicinals)

Branded Legacy, Inc. Acquires MariJ Pharmaceuticals, Inc.

December 4, 2023

Biotechnology

Branded Legacy, Inc. (OTC: BLEG) completed the acquisition of MariJ Pharmaceuticals, Inc., a Clearwater, Florida-based certified-organic CBD extraction and production company, on December 4, 2023. The deal transfers MariJ's mobile CO2 extraction units, licensed vehicles, production lab, IP (including a patent), organic certifications, customer and operational databases, and licenses to Branded Legacy in exchange for preferred series stock and cash.

MariMed Acquires Kind Therapeutics USA

April 27, 2022

Consumer Products

MariMed Inc. completed the acquisition of Kind Therapeutics U.S.A., LLC, a vertically integrated medical cannabis operator in Maryland. MariMed—an OTCQX-listed multi-state cannabis operator based in Norwood, Massachusetts—plans to expand Kind's cultivation canopy, add a GMP kitchen, and roll out new cannabis brands and products across the Maryland market.

KEY Investment Partners Acquires BellRock Brands

January 12, 2026

Consumer Products

KEY Investment Partners purchased BellRock Brands out of receivership, securing the company's brand assets and providing working capital to refocus and revitalize the portfolio. The assets will be operated under a newly formed company, MM Brands, led by incoming CEO Joe Bayern as the business pursues national brand-building ahead of potential federal cannabis rescheduling.

cbdMD Acquires Substantially All Assets of Bluebird Botanicals

January 29, 2026

Consumer Products

cbdMD, Inc. (NYSE American: YCBD) acquired substantially all assets of Bluebird Botanicals in early January 2026 to integrate Bluebird's regulatory science, safety and IP assets into cbdMD's clinical and toxicology platform. The deal strengthens cbdMD's regulatory-compliance and GRAS capabilities for both broad-spectrum and full-spectrum cannabinoid formulations and is expected to contribute to revenue growth and expanded product safety dossiers.

Champignon Brands Acquires AltMed Capital Corp.

April 9, 2020

Healthcare Services

Champignon Brands Inc. has entered into a definitive agreement to acquire 100% of AltMed Capital Corp., a Canadian ketamine clinic operator and psychedelic medicine IP aggregator that owns a majority stake in the Canadian Rapid Treatment Centre of Excellence (CRTCE) in Mississauga. The acquisition gives Champignon clinic SOPs, Health Canada-approved psilocybin dosing capability, existing IP and an early-stage clinical trials portfolio to accelerate its psychedelic medicine and rapid-onset treatment rollout in Canada and the United States.

Jones Soda Co. Sells Mary Jones Cannabis Beverage Business to MJ Reg Disrupters LLC

June 23, 2025

Food & Beverage

Jones Soda Co. has divested its cannabis beverage business (the Cannabis Subsidiaries operating under the Mary Jones brand) to MJ Reg Disrupters LLC for $3.0 million in aggregate consideration (cash plus a promissory note). The sale includes a multi‑year trademark licensing agreement under which MJ Reg will pay annual fees to Jones; the divestiture is part of Jones Soda's strategy to streamline operations and focus on its core soda and adult beverage businesses.